SEM · Select Medical Holdings Corp
Price & Indicators
The closing range uses available history since Jun 30, 2026; less than a full year is stored.
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted earnings per common share non-GAAP | $0.36 | first quarter ended March 31, 2026 | — |
| Adjusted EBITDA non-GAAP | $141.6M | first quarter ended March 31, 2026 | — |
|
|
|||
| Adjusted EBITDA for the critical illness recovery hospital segment non-GAAP | $73.4M | first quarter ended March 31, 2026 | — |
| Adjusted EBITDA margin for the critical illness recovery hospital segment non-GAAP | 11.5% | first quarter ended March 31, 2026 | — |
| Critical illness recovery hospitals | 103 | As of March 31, 2026 | — |
| Outpatient rehabilitation clinics | 1,912 | As of March 31, 2026 | — |
| Rehabilitation hospitals | 41 | As of March 31, 2026 | — |
| Adjusted EBITDA margin non-GAAP | 10.5% | Q4 FY2025 | — |
| Number of admissions | 8,950 | Q4 FY2025 | — |
| Number of clinics operated – end of period | 1,917 | Q4 FY2025 | — |
| Number of hospitals operated – end of period | 104 | Q4 FY2025 | — |
| Number of patient days | 271,417 | Q4 FY2025 | — |
| Number of visits | 2,948,604 | Q4 FY2025 | — |
| Occupancy rate | 67% | Q4 FY2025 | — |
| Revenue per patient day | $2,312 | Q4 FY2025 | — |
| Revenue per visit | $98 | Q4 FY2025 | — |
| Working days | 64 | Q4 FY2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SEM
this stock
Select Medical Holdings Corp
|
$2.05B | — | +5.1% | 15.4 | 0.9% |
|
HCA
HCA Healthcare, Inc.
|
$89.77B | -13.3% | +7.1% | 13.9 | 2.7% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$30.87B | -4.4% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$21.57B | +34.8% | +0.9% | 10.3 | 4.0% |
|
FMS
Fresenius Medical Care AG
|
$12.65B | -0.2% | +5.9% | — | 0.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SEM | — | — | — | — | — |
| SPY | +1.8% | -1.6% | +7.9% | -1.3% | +9.5% |
| vs SPY | — | — | — | — | — |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.